Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect

Author： Xia En-Qin   Zhu Shan-Shan   He Min-Jing   Luo Fei   Fu Cheng-Zhan   Zou Tang-Bin  

Publisher： MDPI

E-ISSN： 1660-3397|15|4|88-88

ISSN： 1660-3397

Source： Marine Drugs, Vol.15, Iss.4, 2017-03, pp. : 88-88

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

By Rendell M.  

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1339-1358

Adis International

Access to resources Recommend Favorite

The incretin system in the management of type 2 diabetes mellitus

By Stephens Jeffrey W  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 491-495

Royal College Of Physicians

Access to resources Recommend Favorite

Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus

By Krentz Andrew J.  

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 385-411

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

By Ward Alexandra   O’Brien Judith A   Salas Maribel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite

Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus

By Hermansen Kjeld   Mortensen Lene S.  

Drug Safety, Vol. 30, Iss. 12, 2007-01 ,pp. : 1127-1142

Adis International

Access to resources Recommend Favorite